Atlas Trials

Multicenter Clinical Study of Anti-VEGF Treatment on High Risk Diabetic Retinopathy (DR)

Clinical trial NCT03452657 · UNKNOWN

Trial details

NCT number
NCT03452657
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetic RetinopathyRanibizumab
Start date
2018-04-01
Primary completion
2019-06-01
Enrollment
118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.